OncANP: Tumor Boards



Tumor Boards
	Tumor Board Archives April 4, 2007 Biology of Cancer; Donald Braun, Ph.D February 5, 2007 Research in Trametes in Oncology Care, Leanna Standish, ND November 13, 2006 A frank and unscripted Discussion on PSA; Scott Tropper, MD and Asif Harsolia , MD April 4, 2007 Title: Biology of Cancer Moderator: Michelle Qaqundah, ND Guest Speaker: Donald Braun, Ph.D Brief Summary This lecture will present basic information/concepts about selected genomic, cellular and pathophysiologic changes intrinsic to the development of malignant diseases. They will focus on the role of these changes in: 1) loss of cell growth control; 2) angiogenesis; 3) metastasis; and, 4) evasion of immunologic recognition and destruction. The relevance of these events to the development of targeted therapeutics will be illustrated and discussed. Biography of Guest Speaker: Donald P. Braun, Ph.D. Vice President of Clinical Research for Cancer Treatment Centers of America . Dr. Donald Braun received his Ph.D. in Microbiology/Immunology from the University of Illinois at the Medical Center . He has over 25 years research experience in immunology, microbiology, inflammatory diseases, oncology, cancer immunology, and cancer immunotherapy. "My focus has been on identifying biological and molecular targets intrinsic to cancer disease processes and applying targeted therapeutics to address those processes," Dr. Braun stated. Dr. Braun has served as an advisor to numerous public agencies concerned with cancer. He served on the Experimental Therapeutics Study Section of the National Cancer Institute. In addition he served on the Experimental Immunology and Immunotherapy Study Section of the American Cancer Society- National Division. Most recently he served as the Administrative Director of the Medical College of Ohio Cancer Institute and formerly as the Scientific Director of Rush Cancer Institute. Dr. Braun has authored approximately 90 published peer-reviewed manuscripts, 20 reviews and book chapters, 130 abstracts and co-edited one book devoted to the use of prostaglandin inhibitors in cancer immunotherapy. February 5, 2007 Title: Research in Trametes in Oncology Care Moderator: Lise Alschuler , ND Guest Speaker: Leanna Standish , ND Brief Summary I will discuss 31 clinical trials from Japan , China , and Korea that indicate that Trametes versicolor (AKA Coriolus versicolor, Turkey Tail) improves survival in cancer patients. The NIH, for the first time, is now funding a clinical trial of T. versicolor in breast cancer. This study is being performed at Bastyr and University of Minnesota . I will discuss product quality assurance and clinical trial design issues, and data thus far from our observational study of immune status in women with breast cancer who have completed conventional cancer treatment. Biographies of Guest Speakers LEANNA J. STANDISH, N.D., Ph.D., L. Acup. Curriculum Vitae January 2007 PRESENT POSITIONS Research Professor School of Naturopathic Medicine Bastyr University 14500 Juanita Drive NE Kenmore, WA 98028 (425) 602-3166 FAX (425) 602-3079 email: ljs@bastyr.edu Clinical Professor School of Public Health University of Washington Principal Investigator NIH funded research grants since 1994 Senior Physician University Health Clinic Specialty Care & Research Center 5322 Roosevelt Way, NE Seattle , WA 98105 (206) 525-8012 ADVISORY POSITIONS • NIAID study section member for Clinical Trials Units 2006 • Appointed Program Committee member for the Society of Integrative Oncology 2005-present • Appointed member of the board of the Oncology Association of Naturopathic Physicians 2004-present • Appointed member of Board of Scientific Counselors for Cancer Treatment Research Foundation 2004 – present • Appointed member of the board of the Oncology Association of Naturopathic Physicians • Appointed member of Scientific Steering committee for Traditional Medicine for Global HIV/AIDS, Senegal , Africa • Appointed to Washington State 's Department of Health's Hepatitis C Strategic Plan Committee August 2003 • Appointed advisory member to Washington State 's Cancer Control Planning Committee April 2003 • Appointed External Advisory Committee Member of the M.D. Anderson Cancer Center Complementary and Alternative Medicine Program, 2001-present • Panel Member, White House Commission on CAM Policy, October 2000 • Appointed Member, NCI Cancer Advisory Panel for Complementary and Alternative Medicine, 1999-2001 • Appointed Advisory Council Member of the NIH National Center for Complementary and Alternative Medicine, August 1999-2001 • Advisory Board Member: Alternative Therapies in Health and Medicine, 1995-present • Technical Advisor to the Health Services Effectiveness Advisory Committee, appointed in 1995 by the Washington State Health Services Commission • Appointed Member of NIH Ad Hoc Panel on Alternative Medicine, 1992-1994 • Scientific Review Board, Seattle Treatment Education Project, 1990-92 EDITORIAL POSITIONS J. Society of Integrated Oncology J. Complementary and Alternative Medicine Explore PREVIOUS POSITIONS Research Director 1987-2000 Senior Research Scientist 2001-2004 November 13, 2006 Title: A Frank and Unscripted Discussion about PSA Moderator: Daniel Rubin, ND, FABNO Guest Speakers: Scott Tropper, MD and Asif Harsolia , MD Brief Summary Given our exceptionally expanding knowledge base of oncogenetics, or the genetics of cancer, and the rapid development of sophisticated technology to treat this disease, there is probably no field of medicine that has undergone quite the revolution in the last decade as radiation oncology. Additionally, with the widespread adoption of PSA [Prostate Specific Antigen] as an effective screening tool to diagnose prostate cancer, we are finally getting closer to our ultimate goal to cure this disease. This tumor board will cover the variable information afforded by PSA measurement in the clinical management of men with prostate cancer. (partially adopted from High Dose Rate Brachytherapy Brings New Hope to Prostate Cancer Patients by Drs. Tropper and Harsolia) Biographies of Guest Speakers SCOTT E. TROPPER, MD EDUCATION College/Medical School Brooklyn College/State University of New York Health Science Center , Brooklyn , New York POST GRADUATE TRAINING Internship : Deaconess Medical Center , Spokane , WA Transitional Year Residency : State University of New York Health Science Center , Syracuse , New York Department of Radiation Oncology CERTIFICATION Diplomat, Radiation Oncology Currently Medical Director of the Center for Radiation Therapy in Scottsdale where he treats patients using advanced technology including Intensity Modulated Radiation Therapy, stereotactic body radiotherapy, low dose real-time brachytherapy and soon high dose brachytherapy. He has lectured and proctored physicians throughout the US and in Bangkok , Thailand ; Seoul , Korea ; and Shanghai , China , in treatments and techniques of prostate brachytherapy. He performed the first real-time prostate implant in all of Asia . ASIF HARSOLIA, MD Dr. Harsolia is originally from Michigan where he completed his undergraduate studies from the University of Michigan in Ann Arbor (Bachelor of Science). He went on to complete his Medical Studies at the University of Michigan Medical School and his internship at William Beaumont Hospital in Royal Oak , Michigan . He completed his Radiation Oncology residency training also at William Beaumont Hospital at one of the leading departments in Radiation Oncology and High Dose Rate (HDR) Brachytherapy. He has done research and published on breast cancer, prostate cancer, and lung cancer as well as on Intensity Modulated Radiation Therapy (IMRT) and 4D Image Guided radiation techniques. He has won numerous awards for his research including the American Society for Therapeutic Radiology and Oncology (ASTRO) clinical research award and has presented at a number of national and local scientific conferences. He currently lives in Scottsdale with his wife and their 9-month-old son and practices at the Arizona Cancer Institute in Scottsdale , Arizona.